A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy - CAMBRIA-1 - AstraZenecaSee more
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) - CAMBRIA-2 - AstraZenecaSee more
Colorectal cancer
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more
Diabetes
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes - ATTAIN-2 - Eli Lilly and CompanySee more
Neuromyelitis optica
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) - SAkuraSun - Hoffmann-La RocheSee more
Obesity
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes - ATTAIN-2 - Eli Lilly and CompanySee more
